Gary S. Jacob, Director at Hepion Pharmaceuticals, Inc. (HEPA), bought 12,000 shares at $1.66 ($20K) on 2020-12-01, disclosed to the SEC on 2020-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| VRPX | BUY | 2021-02-19 | $24K | — | Filing → |
| CRDF | BUY | 2020-05-18 | $25K | — | Filing → |
| SGYP | BUY | 2017-05-30 | $20K | — | Filing → |